Agile Therapeutics, Inc. (AGRX)

Agile Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2.85	2.56	5.25	19.14	14.46	34.48
Short-Term Investments	-	-	-	-	40.01	-
Cash & Short-Term Investments	2.85	2.56	5.25	19.14	54.47	34.48
Cash Growth	2.26%	-51.26%	-72.60%	-64.86%	57.98%	339.17%
Receivables	4.55	3.39	3.38	1.53	0.87	-
Inventory	5.79	2.74	1.33	0.97	-	-
Prepaid Expenses	0.13	0.44	0.63	0.78	0.68	0.84
Other Current Assets	1.12	0.4	0.78	1.51	0.77	-
Total Current Assets	14.44	9.53	11.36	23.93	56.79	35.32
Property, Plant & Equipment	0.28	0.49	0.87	13.4	14.38	14.2
Other Long-Term Assets	0.24	0.24	2.01	2.01	1.9	0.02
Total Assets	14.96	10.26	14.24	39.33	73.06	49.54

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	16.54	9.57	7.73	8.71	3.87	1.82
Accrued Expenses	9.4	9.13	3.91	3.56	3.35	1.8
Short-Term Debt	-	0.19	-	-	-	-
Current Portion of Long-Term Debt	-	1.52	1.43	16.83	-	-
Current Portion of Leases	0.29	0.37	0.32	0.18	0.14	0.17
Total Current Liabilities	26.23	20.78	13.39	29.28	7.35	3.8
Long-Term Debt	-	-	-	-	16.38	-
Long-Term Leases	-	0.1	0.47	0.78	-	-
Other Long-Term Liabilities	10.65	5.7	5.93	5.36	-	-
Total Liabilities	36.88	26.57	19.79	35.42	23.73	3.8

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	0.01	0	-	-	0.01	0.01
Additional Paid-In Capital	411.84	406.85	403.16	387.21	361.54	306.11
Retained Earnings	-433.76	-423.17	-408.7	-383.29	-312.22	-260.37
Comprehensive Income & Other	-	-	-	-	0	-
Total Common Equity	-21.91	-16.32	-5.55	3.92	49.33	45.75
Shareholders' Equity	-21.91	-16.32	-5.55	3.92	49.33	45.75
Total Liabilities & Equity	14.96	10.26	14.24	39.33	73.06	49.54

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	0.29	2.17	2.21	17.79	16.52	0.17
Net Cash (Debt)	2.56	0.39	3.04	1.35	37.95	34.31
Net Cash Growth	2712.09%	-87.31%	124.65%	-96.44%	10.63%	336.98%
Net Cash Per Share	0.59	0.18	7.02	27.84	896.32	1388.05
Filing Date Shares Outstanding	6.9	6.86	0.93	0.07	0.04	0.03
Total Common Shares Outstanding	6.9	2.96	0.86	0.06	0.04	0.03
Working Capital	-11.79	-11.25	-2.03	-5.35	49.43	31.52
Book Value Per Share	-3.17	-5.51	-6.45	64.50	1126.67	1310.56
Tangible Book Value	-21.91	-16.32	-5.55	3.92	49.33	45.75
Tangible Book Value Per Share	-3.17	-5.51	-6.45	64.50	1126.67	1310.56
Machinery	-	0.25	0.25	14.6	14.33	14.43

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error